FN1 and neoplasm: The miR‐4736 antagomir‐treated group showed stagnancy in tumor growth as manifested by smaller tumor volume, decreased levels of fibronectin, collagen 1, α‐SMA, and Ki67, and increased levels of ATG7 (Figure 6B–G).